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    Mice were irradiated lethally with gamma-rays under high dose rate and were treated 
 with preserved isologous bone marrow. 
    The isologous bone marrow cells were suspended in 15% V/V glycerol-Tyrode's olution 
 at —80°C as long as 450 days. As to the survival rate at 30 days after irradiation, the 
 isologous bone marrow within 360 days preservation protected well the lethally gamma-
 irradiated mice as well as the fresh isologous bone marrow transplantation did, as far as 5 
 million of nucleated cells were injected. 
                          INTRODUCTION 
   In acute radiation death, it is well known that three different mechanisms1" 
of death resulting from the injuries of the central nervous system, intestinal 
tract or hematopoietic system must be considered separately. Radiation death 
from the central nervous system 3,4," occurs within minutes or hours after ex-
posure when animals are exposed to the supralethal radiation dose (kiloroentgen). 
Intestinal death occurs 3-5 days after exposure, associated with sever and conti-
nuous diarrhoea.6'" Damage to the intestinal mucosa is the major cause of these 
symptoms. Apparently the denuded mucosa can not absorb enough water and 
electrolytes to prevent dehydration, salt loss, and other changes that are the 
immediate cause of death. 
   Radiation death from the hematopoietic system is one of the most important 
causes of death after total-body irradiation. Destruction of bone marrow is the 
most critical event in terms of nearly total loss of hematopoietic system and 
subsequently, extremely small numbers of granulocytes and platelets in peripheral 
blood are followed by bacterial invasion " and hemorrhage ". Bacterial infection 
and hemorrhage are the immediate causes of acute radiation death. The anemia 
resulting from the bone marrow failure is little significance in acute radiation 
death. 
   In 1951, Lorenz and coworkers") reported the first successful experiments in 
which the intravenous or intraperitoneal injection of isologous bone marrow 
protected well the total-body lethally irradiated mice from hematopoietic death. 
* r: 
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   The long term preservation of bone marrow cells is essentially necessary for 
the clinical application of bone marrow transplantation. In 1949, Polge, Smith, 
and Parkers"' reported the successful preservation under freezing and thawing 
of bovine spermatozoa using glycerine as a protective medium. And then many 
workers reported the transplantation of the bone marrow cells preserved at low 
temperature in use of glycerol as a protective could improve the survival of 
lethally irradiated mice. In 1959, Lovelock and Bishop12j showed that dimethyl 
-sulphoxide protects living cells against freezing injury in a fashion very similar 
to that of glycerol, and M. J. Ashwood-Smith") used dimethyl-sulphoxide to 
protect mouse bone marrow against the damaging effects of freezing to and 
thawing from low temperature. 
   The following experiments were undertaken to ascertain the method of free-
zing and thawing for the preservation of the hematopoietic cells and to observe 
the protective effect of the isologous bone marrow cells which were preserved at 
—80°C as long as 450 days upon the lethally irradiated mice. 
                     MATERIALS AND METHODS 
   Mice. Dd/s strain mice supplied from the Kyoto University Animals Center 
were used as the recipients and isologous bone marrow (IBM) donors. They were 
8 to 9 week old female mice, weighing approximately 20-25g at the experiments. 
After irradiation and treatment, 8 to 10 mice were kept in wooden boxes measuring 
15x21x30cm, and were fed wheat, dried fish (each other day) and were given 
tap water ad libitum. 
   Bone marrow cell suspensions. The donor mice were sacrificed by neck 
fracture and bilateral tibias and femurs were removed aseptically."' Both ends of 
the boxes were cut, a small needle (size 1/5, used usually for tuberculin tests) 
was inserted into one end, and the bone marrow was flushed directly from the 
bilateral femurs and tibias with the cold sterile Tyrode's solution or TC199 
(Difico) solution and bone marrow cells in it were washed out. Glycerol was 
added to Tyrode's solution so as to make the final concentration of 15% (V/V) 
''-Z" and dimethyl-sulphoxide (DMSO) was added to TC199 solution so as to make 
the final concentration of 10% (V/V).12,13,2d-2" There were suspended 20x10' 
nucleated bone marrow cells in 1.2cc of 15% glycerol-Tyrocle's solution or 10% 
DMSO-TC199 solution. An ampoule containing 3.6cc of the bone marrow suspens-
ions was sealed with flame. Each recipient, except the mice in the control group, 
was given 5 x 10' nucleated bone marrow cells via the tail vein within 4 to 6 
hours after irradiation. The mice in control were lethally irradiated without 
any further treatment or were injected intravenously 0.5ml of Tyrode's solution 
after irradiation. There were contained 5 10' nucleated bone marrow cells in 
0.3m1 of the bone marrow cells soaspensin and glycerol or DMSO was not removed 
when the suspension was used. However, the suspension was diluted with 0.3m1 
of Tyrode's solution when it was used. So that the final concentration of the 
compound injected was thus one-half that used for freezing. 
Freezing and thawing. Slow","'"-3°' freezing was carried out so that the 
temperature was lowered 1-2°C/min. from 0°C until --25°C and then lowered to 
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—80°C at a rate not exceeding 10°C/min. The ampoules were placed in a metal 
box containing ice pieces. The ampoules were removed from the metal box and 
then placed into a plastic box which contained about 200m1 of ethanol and it was 
cooled to 0°C by dry ice. About 2-3g of pieces of dry ice cooled the bath of the 
plastic box at a rate 1°C/min. 
   The second step of slow freezing was achieved by adding dry ice pieces into 
the plastic box cooled by the first step. As coolant solid CO2 was used and 
about lOg dry ice cooled the plastic box bath at a rate less than 10°C/min. from 
—25°C to —80°. When —80°C was reached, the ampoules were rapidly transferred 
to another Dewar-flask containing a —80°C ethanol-frozen CO2 mixture and stored 
in it. 
   Rapid freezing. When rapid freezing was necessary, the ampoules were rapidly 
placed in the Dewar-flask containing a —80°C ethanol-frozen CO2 mixture. 
   Fast thawing. The ampoules were removed from the Dewar-flask and the 
contents were thawed in a 37°C water bath and in one minute were completely 
liquefied by stirring. 
   Slow thawing. The ampoules were removed from the Dewar-flask and placed 
in room temperature or in air at 4°C until the frozen contents were completely 
liquef ied. 
   Cell viability. In these experiments eosin staining method3',32, was used and 
the dye in minute quantities was added to the cell suspension and the exclusion 
or incorporation of the dye by the cells was observed microscopically. The ratio 
of cells stained or not against the counted cells was determined by direct coun-
ting. But the exposure of the cell suspension to the dye solution for a period 
longer than 5 minutes resulted in a substantial reduction of dye-excluding cells. 
This eosin staining test was used as a screenig test. Eosin-uptake was measured 
on many of the bone marrow suspensions both before and after freezing. In 
every case one drop of 1:500 eosin in Tyrode's solution was added directly to one 
drop of the bone marrow suspensions on the slide glass. And a cover slip was 
placed over the mixtured suspension. Stained cells were suspected to be dead 
and the percentage of nonviable bone marrow cells (stained cells) in counted 
total bone marrow cells was described. 
   Irradiation. A Co" gamma-irradiation facility which belongs to the Institute 
for Chemical Research of Kyoto University was used in the present experiments. 
This facility is described in detail elsewhere.33,3"> Four to five mice were placed 
in a 10 x 10 >:10cm. paper box which was then placed at the center of an alumi-
num container. The container with the box was moved in and out of the place 
of irradiation (A or B in Fig. 1) as quickly as possible in order for the mice not 
to be exposed to an extra dose of gamma-rays before and after receiving a 
certain dose of irradiation. Mice placed at A can be expected to be irradiated 
under single, total-body dose, because gamma-rays come from practically all 
directions. Those placed at B, however, can not be expected to be so, because 
gamma-rays come from one side and the distance from the cylindrical array to 
each animal in the box varies a little. 
   All recipients were exposed to a single LD9°/14-day, LD'°°/21-day dose of 
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total-body irradiation of 900r which was obtained for 27 sec. in October, 1962, 
and for 32 sec. in October, 1964. 
Coe° cylindrical array 
trAtp 
conveyer, 
                               Aluminum container
                        Fig 1. Co" T-ray irradiation facility. 
                             RESULTS 
   1. Some Observations on the Basic Method of Preservation of Mouse Bone 
Marrow 
   Experiment 1. This experiment was carried out to protect the lethally irradi-
ated mice by IBM cells which were suspended in Tyrode's solution and preserved 
in a refrigerator (0-4°C) for short term. Table 1 shows the survival rates of 
      Table 1. Survival of gamma-irradiated mice treated with isologous bone marrow 
         preserved at 0-4°C for 4, 7 and 14 days. 
                          Percent Number of survival 
 Preservation No. of staining(at days)%Survival 
  period experiment with eosin(at days) (%) Number of ir adiated 
                    14 30 60 9014 30 60 90 
  Control 44—2/162 0/162 — —1 0 — — 
  Fresh29 14/19 13/19 13/19 13/1974 68 68 68 
  4 days1644/8 3/8 3/8 3/850 37 37 37 
  7 days1736/8 4/8 3/8 3/875 50 37 37 
 14 days1970/80 — — — 
      The number of nucleated cells injected was 5 million. They were suspended in 
   Tyrode's solution and presesrved at 0-4°C. 
      Control means the group of gamma-irradiated mice treated with Tyrode's solution 
   or nothing. 
      Fresh means the group of gamma-irradiated mice treated with isologous bone marrow. 
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         Fig. 2. Leucocyte count in gamma-irradiated mice treated with preserved . 
             isologous bone marrow at 0-4°C. 
           The number of nucleated cells injected was 5 million. 
            Preservation was carried out in Tyrode's solution for 4, 7 and 14 days. 
            Fresh means the group of gamma-irradiated mice treated with fresh 
             isologous bone marrow. 
            Control means the group of gamma-irradiated mice treated with only 
            Tyrode's solution or nothing. 
        Fig. 3. Reticulocyte count in gamma-irradiated mice treated with preserved 
             isologous bone marrow at 0-4°C. 
           The number of nucleated cells injected was 5 million. 
            Preservation was carried out in Tyrode's solution for 4, 7 and 14 days. 
            Fresh means the group of gamma-irradiated mice treated with fresh 
             isologous bone marrow. 
            Control means the group of gamma-irradiated mice treated with only 
            Tyrode's solution or nothing. 
irradiated mice treated with the preserved IBM transplantation and Figures 2 
and 3 show the changes of leucocyte count and reticulocyte count in peripheral 
blood. The results showed that the IBM preserved for 4 days at 0-4°C could not 
already protect the lethally irradiated mice as well as the fresh IBM, and the 
IBM stored for 14 days at 0-4°C could not protect the early acute death of 
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lethally irradiated mice. As compared to the fresh IBM transplantation, this 
experiment indicated that the viability of bone marrow cells which were preserved 
at 0-4°C could be restained within 3 days. The survival rates at 30 days were 
as follows: 68% in the fresh IBM transplantation, 37% in the 4 days preserved 
IBM treatment, 50% in the 7 days preserved IBM treatment, and 0% in the 14 
days preserved IBM treatment, respectively. 
   Experiment 2. This experiment was made to protect the lethally irradiated 
mice with IBM cells which were stored for 2 hours at --80°C without the prote-
ctive additives. The IBM cells were suspended only in Tyrode's solution and 
were frozen and thawed rapidly. The percentage of eosin-staining cells in all 
counted cells was 100% and the survival rate at 14 postexposure days was 0% 
(0/8). This result showed that the cell viability was lost due to the freezing and 
thawing without protectives during the storage for 2 hrs at —80°C. 
   Experiment 3. This experiment was carried out to find the number of the 
bone marrow cells which could protect half of the lethally irradiated mice. The 
bone marrow cells were suspended in Tyrode's solution. The survival rates at 30 
days after irradiation were as follows: when the number of nucleated cells 
injected was 0.1 x 106, 0.5 x 106, 1 x 106, and 2 x 106, the survival rate was 0%, 50%, 
50% and 50%, respectively. So that the number of the bone marrow cells require 
for effective protection was 0.5 x 106 or less. 
   Experiment 4. For the mouse bone marrow preservation was used 15% glycerol-
Tyrode's solution or 10% DMSO-TC199. The methods of freezing and thawing 
were various combinations of slow or fast freezing and slow or fast thawing. 
      Table 2. Survival rate of gamma-irradiated mice treated with preserved IBM. 
                              Percent   Method ofN umber ofsurvival 
  freezing,No. ofstainingooSurvival     thawinexperiment with e)sin Number of irradiated(at days) (at days) 
                      14 30 60 90 14 30 60 90 
  Control 44— 2/162 0/162 — — 1 0 — — 
  Fresh29 14/19 13/19 13/19 13/19 74 68 68 68 
G141 3/8 2/8 2/8 2/8 37 25 25 25 // 
D123 6/8 5/8 5/8 5/8 75 62 62 62 
G114 8/8 7/8 7/8 7/8 100 87 87 87   /1 
D123 6/8 6/8 6/8 6/8 75 75 75 75 
G162 4/8 3/8 3/8 3/8 50 37 37 37 1/ 
D149 4/8 3/8 3/8 3/8 50 37 37 37 
G192 2/8 2/8 2/8 2/8 25 25 25 25 IT 
D190 3/8 3/8 3/8 3/8 37 37 37 37 
   The number of nucleated cells injected was 5 million. They was preserved for 2 
   hours at —80°C. 
   G means that IBM was suspended in 15% glycerol-Tyrode's solution. 
  D means that IBM was suspended in 10% DMSO-TC199. 
   Control means the group of gamma-irradiated mice treated with only Tyrode's solution 
   or nothing. Fresh means the group of gamma-irradiated mice treated with fresh IBM. 
   •means slow freezing of the hone marrow cells. 
1 means fast freezing of the bone marrow cells. 
      means fast thawing frozen bone marrow. 
   / means slow thawing frozen bone marrow. 
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      Fig. 4. Body weight changes in mice irradiated lethally and treated with pre-
          served isologous bone marrow for 2 hours at -80°C. The number of nucleated 
          cells injected was 5 million. 
          Control means the group of gamma-irradiated mice treated with only Tyr-
           ode's solution. 
         Fresh means the group of gamma-irradiated mice treated with fresh isologous 
           bone marrow. 
          The upper figure shows body weight changes in mice irradiated lethally and 
          treated with IBM suspended in 15% glycerol-Tyrode's solution.
         The lower figure shows body weight changes in mice irradiated lethally and 
         treated with IBM suspended in 10% DMSO-TC199. 
         1 means body weight changes in mice treated whih IBM which was slow 
            frozen, stored and used after slow thawing. 
         2 means body weight changes in mice treated with IBM which was slow 
            frozen, stored and used after fast thawing. 
         3 means body weight changes in mice treated with IBM which was fast 
            frozen, stored and used after slow thawing. 
         4 means body weight changes in mice treated with IBM which was fast 
            frozen, stored and used after fast thawing. 
The survival rate of mice treated with fresh IBM was 74% at 14 days, 68% 
30 days, 68% at 60 days and 68% at 90 days after irradiation, while, the survival 
rate of control group in which the lethally irradiated mice were treated only 
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with  Tyrode's solution without any cell suspension was 1% at 14 days and 0% 
at 21 postexposure days. The bone marrow nucleated cells were suspended in 
15% glycerol-Tyrode's solution. The survival rates were shown in Table 2, and 
the changes of body weight were shown in Fig. 4. The survival rate of mice 
treated with IBM in 15% glycerol-Tyrode's solution by slow freezing and slow 
thawing ,was 37% at 14 days and 25% at 30 days after irradiation. The survival 
rate of mice treated with preserved IBM in 10% DMSO-TC199 by the same method 
was 75% at 14 days and 62% at 30 days after irradiation. 
   The survival rate of mice treated with preserved IBM in 15% glycerol-
Tyrode's solution by slow freezing and fast thawing was 87% at 30 days after 
irradiation. The survival rate of mice treated with IBM in 10% DMSO-TC199 
by the same method was 75% at 30 days after irradiation. The survival rate of 
mice treated with preserved IBM in 15% glycerol-Tyrode's solution or 10% 
DMSO-TC199 by fast freezing and slow thawing was 37% and 37% at 30 days 
after irradiation, respectively. The survival rate of mice treated with preserved 
IBM in 15% glycerol-Tyrode's solution or 10% DMSO-TC199 by fast freezing and 
fast thawing was 25% and 37%, respectively. 
   The best survival rate was obtained by the method of slow freezing and 
fast thawing in 15% glycerol-Tyrode's solution and 10% DMSO-TC199. In the 
case of 10% DMSO-TC199, however, the good survival rate was obtained by the 
method of fast freezing and fast thawing. In order to freeze the mouse bone 
marrow nucleated cells for low temperature storage, the method of slow freezing 
and fast thawing is the fundamental procedure. 
   2. Observations on Long-term Preservation of Mouse Bone marrow at —80°C 
   This experiment was carried out to protect the lethally irradiated mice with 
the IBM cells which were preserved as long as 450 days at —80°C. The mouse 
bone marrow cells were suspended in 15% glycerol-Tyrode's solution and were 
stored at —80°C by slow freezing and used after thawing. 
   1) Survival rate. The survival rates in thirteen experiments are shown in 
Table 3 and Fig. 5. Observation period was 90 days after irradiation and the 
survival rate of mice treated with fresh IBM was 74% at 14 days, 68% at 60 
days after irradiation, and 68% at 90 days after irradiation. In 150 days pre-
served IBM transplantation, the survival rate was 71% at 30 days, and 42% at 90 
days after irradiation. In 270 days preserved IBM transplantaion, the survival 
rate was 71% at 30 days, and 71% at 90 days after irradiation. In one year (360 
days) preserved IBM transplantation, the survival rate was 64% at 30 days, 
47% at 60 days, and 29% at 90 days after irradiation. As for the survival rates 
at 30 days after irradiation, these were 40% to 84% and the survival rates at 
90 days after irradiation, these were 29% to 76%. Consequently, the bone marrow 
cells were still effectvie after as long as one year preservation. As far as the 
survival rate at 90 days after irradiation is concerned, 360 days preserved IBM 
and 450 days preserved IBM transplantation could not protect the lethally 
irradiated mice as well as the fresh IBM transplantation. 
   Cell viability. As an index of cell viability the exclusion of dye (eosin) was 
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        Fig. 5. Changes of percent survival in mice irradiated lethally and treated 
with preserved isologous bone marrow at -80°C. The number of nucleated 
            cells injected was 5 million. Preservation was carried out in 15% glycerol-
           Tyrode's solution for 30, 60, 90, 120, 150, 180, 270, 360 and 450 days. 
       Table 3. Survival rate of gamma-irradiated mice treated with preserved IBM. 
PercentNumber of survival 
 Preservation No. of stainingo, 
   period experiment with eosin(at days)oSurvival 
                          (%)Number of irradiated 
                       14 21 30 60 90 21 30 60 90  
   Control 44— 2/162 0/162 — — — 0 — — — 
    Fresh29 14/19 13/19 13/19 13/19 13/19 68 68 68 68 
    10 days 218 1.6/20 16/20 15/20 13/20 13/20 80 75 65 65 
    20 days 221 17/24 16/24 16/24 16/24 16/24 65 65 65 65 
    30 days 221 10/17 10/17 10/17 10/17 10/17 58 58 58 58 
   60 days 127 7/8 7/8 6/8 6/8 6/887 75 75 75 
    90 days 133 6/10 6/10 6/10 5/10 5/10 GO 60 50 50 
    120 days 229 12/13 12/13 11/13 10/13 10/13 92 84 76 76 
    150 days 258 12/14 10/14 111/14 6/14 6/14 71 71 42 42 
    180 days 360 12/16 11/16 11/16 10/16 10/16 68 68 62 62 
    270 days 270 12/15 10/14. 10/14 10/14 10/14 71 71 71 71 
    360 days 378 15/17 11/17 11/17 8/17 5/17 64 64 47 29 
    450 days 391 20/21 11/21 8/20 6/20 6/20 54 40 30 30 
      The number of nucleated cells injected was 5 million. They were preserved for 10 
   to 450 days at —80°C in 15% glycerol-Tyrode's solution. 
      Control means the group of gamma-irradiated mice treated with only Tyrode's solution 
   or nothing. 
      Fresh means the group of gamma-irradiated mice treated with fresh isologous hone 
marrow. 
tested. In fresh IBM were eosin uptake cells 9%, and, generally speaking, long term 
preservation resulted in more eosin-uptake. In 450 days preserved IBM, eosin-uptake 
cells were 91%. 
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   Fig. 6. Body weight changes in mice irradiated lethally and treated with 
       preserved isologous bone marrow at -80°C. Preservation was carried out 
       in 15% glycerol-Tyrode'ssolution for 30, 60 and 90 days. The number 
       of nucleated cells injected was 5 million. Fresh means the group of 
       gamma-irradiated mice treated with fresh IBM. Control means the group 
       of gamma-irradiated mice treated with only Tyrode's solution or nothing. 
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   Fig. 7. Body weight changes in mice irradiated lethally and treated with 
       preserved isologous bone marrow at -80°C. Preservation was carried out 
       in 15% glycerol-Tyrode's solution for 120, 150, 180, 270, 360and 450 days. 
       The number of nucleated cells injected was 5 million.
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   2) Body weight changes Body weight changes are shown in Fig. 6 and Fig. 7. 
In the controls the weight loss continued until their death occurring within two 
weeks after irradiation. 
   Mice treated with preserved IBM showed a marked continuous weight loss for 
the eleven days following gamma-irradiation. However. the weight loss stopped at 
5 to 11 days after irradiation and gradually increased thereafter. Except the mice 
treated with 270 days and 360 days preserved IBM, the body weight decreased 
to approximately 90 % of the preirradiation level and it took 8 days in mice 
treated with fresh IBM, 10 days in mice treated with 30 days preserved IBM, 6 
days in mice treated with 60 days preserved IBM, 9 days in mice treated with 90 
days preserved IBM, 7 days in mice treated with 120 days preserved IBM, 8 days 
in mice treated with 150 days preserved IBM, 9 days in mice treated with 180 
days preserved IBM, 10 days in mice treated with 270 days preserved IBM, 9 days 
in mice treated with 360 days preserved IBM, and 9 days in mice treated with 
450 days preserved IBM. The weight loss of mice treated with 270 days preserved 
IBM decreased to approximately 87% of the preirradiation level and the weight 
loss of mice treated with 360 days preserved IBM decreased to about 84% of the 
pre-irradiation level. 
   Until the body weight recovered to the pre-irradiation level, it took 15 days 
in mice treated with fresh IBM, 22 days in mice treated with 30 days preserved 
IBM, 14 days in mice treated with 60 days preserved IBM, 15 days in mice treated 
with 90 days preserved IBM, 12 days in mice treated with 120 days preserved 
IBM, 17 days in mice treated with 150 days preserved IBM, 17 days in mice treated 
with 180 days preserved IBM, 18 days in mice treated with 270 days preserved 
IBM, 60 days in mice treated with 360 days preserved IBM, and 23 days in mice 
treated with 450 days preserved IBM. Namely, a retarded recovery of body weight 
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        Fig. 8. Changes of leucocyte counts in mice irradiated lethally and treated 
            with preserved isologous bone marrow at -80°C. The number of nucleated 
           cells injected was 5 million. Preservation was carried out in 15% glycerol-
           Tyrode's solution for 10 and 20 days. Control means the group of gamma-
           irradiated mice treated with only Tyrode's solution or nothing. Fresh 
           means the group of gamma-irradiated mice treated with fresh IBM. 
( 74 )
                    Preserved Hematopoietic Tissues for Treatment of Mice (I) 
                XICx 
               120 
              100 
 80 
60 \ 
------ 30-days                                                                                    9" 
40/---- 90-days 
I' /'------60-days        20, 
                  2 6 10 14 18 22 26 30 40 50 days 
              Fig. 9. Changes of leucocyte counts in mice irradiated lethally and treated 
                  with preserved IBM at -80°C. The number of nucleated cells injected was 
                  5 million. Preservation was carried out in 15% glycerol-Tyrode's solution 
                for 30, 60 and 90 days. 
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             Fig. 10. Changes of leucocyte counts in mice irradiated lethally and treated 
                  with preserved IBM at -80°C. The number of nucleated cells injected 
                  was 5 million. Preservation was carried out in 15 % glycerol-Tyrode's 
                solution for 120 150, 180, 270, 360 and 450 days.
    for 2 to 8 days was found in mice treated with the preserved IBM, as compared 
    to mice treated with the fresh IBM. But the recovery of body weight in mice with 
    360 days preserved IBM was retarded to 60 days after irradiation. 
        3) Hematological findings. a) Leucocyte count. The changes of leucocyte 
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       Fig. 11. Changes of the percentage of neutrophils in mice irradiated lethally 
           and treated with preserved IBM at -80°C. The number of nucleated cells 
           injected was 5 million. Preservation was carried out in 115% glycerol-
           Tyrode's solution for 30, 60, 90, 120, 150, 180, 270, 360 and 450 days. 
           Fresh means the group of gamma-irradiated mice treated with fresh 
            isologous bone marrow. 
count in peripheral blood were shown in Fig. 8, Fig. 9, and Fig. 10. Leucocyte count 
in peripheral blood was investigated every other day for 21 days after irradiation 
and weekly for 22 to 40 days after irradiation. The leucocyte count in both controls 
and treated mice showed a rapid decrease, 2000 to 4000 at 2 days after irradiation, 
and less than 500 at 4 days after irradiation. In controls there was no increase in 
leucocyte count up to the time of death. In treated mice the leucocyte count began 
to increase at 6 to 7 days after irradiation. At 10 days after irradiation, the leuc-
ocyte count was 6000 in fresh IBM transplantation, 4000 in 90 days preserved IBM, 
1000 in 150 days preserved IBM transplantation, 1000 in 360 days or 450 days pres-
erved IBM transplantation. Then it gradually or quickly approached normal levels. 
The time required for recovery to normal level was 19 days in fresh IBM, 25 days 
in 30 days preserved IBM transplantation, 21 days in 90 days preserved IBM 
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transplantation, 13 days in 120 days preserved IBM transplantation, 16 days in 150 
days preserved IBM transplantation, 28 days in 180 days preserved IBM transpl-
antation, 14 days in 270 days preserved IBM transplantation and 20 days in 450 
days preserved IBM transplantation. Namely, the period for recovery in this expe-
riment was not always later than that in fresh bone marrow transplantation. 
Neutrophils percentage. The changes of neutrophils percentage in peripheral blood 
were shown in Fig. 11. In the peripheral blood of mouse the difference between 
lymphocyte and monocyte was not clear, so that lymphocyte and monocyte were 
described as mononuclear cells. Neutrophils percentage is neutrophile leucocytes 
/neutrophile leucocytes-1-mononuclear cells. Peaks of neutrophils appeared between 
9 to 25 days after irradiation and the peaks appeared later in long term preser-
vation. The peaks recovered to normal level of pre-irradiation between 25 to 45 
days after irradiation. 
   b) Erythrocyte count, reticulocyte count and hemoglobin content. The changes 
in the erythrocyte count following irradiation were shown in Fig. 12 and Fig. 13. 
The changes in erythrocyte count following irradiation were less than in leucocyte 
count. There was no apparent difference in erythrocyte count between the control 
mice and the treated groups 5 days after irradiation. The lowest level of the 
erythrocyte count was found at 2 to 16 days after irradiation and the count 
recovered to the level of pre-irradiation between 26 to 35 days after irradiation. 
   The changes in the reticulocyte count were shown in Fig. 14 and Fig. 15. 
The reticulocyte count in the controls decreased to zero by 2 days after irradiation. 
The reticulocyte count in the preserved IBM transplantations decreased to zero 
by 4 to 5 postexposure days. It increased up at 6 days. All groups of the mice 
treated with preserved IBM showed one reticulocyte crisis. The peak of reticulocyte 
count appeared at 12 days in mice treated with fresh IBM, at 19 days in mice 
s 
X 




   5--- 9O-days 
                                                         60-days
4---- 30-days 
2 4 6 10 14 18 22 26 30 40                                                    daysY 
        Fig. 12. Changes of erythrocyte counts in mice irradiated lethally and treated 
           with preserved IBM at -80°C. The number of nucleated cells injected 
            was 5 million. Preservation was carried out in 15% glycerol-Tyrode's 
           solution for 30, 60 and 90 days. Control means the group of gamma-
            irradiated mice treated with only Tyrode's solution or nothing. Fresh 
           means the group of mice irradiated lethally and treated with fresh IBM. 
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treated with 30 days preserved IBM, at 11 days in mice treated with 120 days 
preserved IBM, at 12 days in mice treated with 270 days preserved IBM, at 12 
     x106 
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_---- — 15 0 days 
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         _ !1\ f / /0 270days 
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• 450 days 
     5 
102 03 0 days after irrad. 
       Fig. 13. Changes of erythrocyte counts in mice irradiated lethally and tre-
           ated with preserved IBM at -80°C. The number of nucleated cells injected 
            was 5 million. Preservation was carried out in 15 % glycerol-Tyrode's 
          solution for 120, 150, 180, 270, 360 and 450 clays.
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        Fig. 14. Changes of reticulocyte counts in mice irradiated lethally and tre-
            ated with preserved IBM at -80°C. The number of nucleated cells injected 
            was 5 million. Preservation was carried out in 15 % glycerol-Tyrode's 
           solution for 30, 60 and 90 clays. Control means the group of gamma-
            irradiated mice treated with only Tyrode's solution or nothing. Fresh 
            means the group of gamma-irradiated mice treated with fresh IBM. 
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        Fig. 15. Changes of reticulocyte counts in mice irradiated lethally and tre-
           ated with preserved IBM at -80°C. The number of nucleated cells injected 
           was 5 million. Preservation was carried out in 15 % glycerol-Tyrode's 
          solution for 120, 150, 180, 270, 360 and 450 days.
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        Fig. :16. Changes of platelet counts in mice irradiated lethally and treated 
           with preserved IBM at -80°C. The number of nucleated cells injected 
           was 5 million. Preservation was carried out in 15 % glycerol-Tyrode's 
           solution for 30, 60 and 90 days. Control means the group of gamma-
           irradiated mice treated with only Tyrode's solution or nothing. Fresh 
            means the group of gamma-irradiated mice treated with fresh IBM. 
clays in mice treated with 360 days preserved IBM, and at 15 days in mice treated 
with 450 days preserved IBM. Namely, the peaks of reticulocyte count appeared 
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        Fig. 17. Changes of platelet counts in mice irradiated lethally and treated 
            with preserved IBM at -80°C. The number of nucleated cells injected was 
            5 million. Preservation was carried out in 15% glycerol-Tyrode's solution 
          for 120, 150, 180, 270, 360 and 450 days. 
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        Fig. 18. Changes of hemoglobin contents in mice irradiated lethally and tre-
           ated with preserved IBM at -80°C. The number of nucleated cells injected 
            was 5 million. Preservation was carried out in 15 % glycerol-Tyrode's 
            solution for 30, 60 and, 90 days. Control means the group of gamma-
           irradiated mice treated with only Tyrode's solution or nothing. Fresh 
           means the group of gamma-irradiated mice treated with fresh IBM. 
between 11 to 19 clays after irradiation. And the reticulocyte count recovered to 
the pre-irradiation value at about 22 to 30 days after irradiation. 
   The changes of platelet count in peripheral blood were shown in Fig. 16 
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and Fig. 17. The platelet count in controls rapidly decreased, showing temporary 
increase, to the level of 12 x  104. The platelet count in the treated mice with 
preserved IBM decreased to the level of 18 to 19 x 104 about 9 to 13 postexposure 
days and then increased rapidly or gradually up to the level of pre-irradiation at 16 
to 30 days after irradiation. However, in this experiment there were found some 
cases which showed two phases in the changes of platelet count. The second lower 
level of the platelet count appeared at 19 to 21 days after irradiation in mice 
treated with fresh IBM, 150 days, 360 days, and 450 days preserved IBM. 
   The changes of hemoglobin content (Sahli) in peripheral blood were shown 
in Fig. 18 and Fig. 19. The hemoglobin content in controls rapidly decreased to 
the level of 80%. The hemoglobin content in the treated mice with preserved IBM 
decreased to the level of 85-100% at about 6 to 15 days after irradiation and then 
increased up to the level of pre-irradiation at 16 to 23 days after irradiation. 
        120 t, - /prservaaon time 
---------- 120 days 
    110——150days 
/e 180 days 
100 y ` 270days 
---- 360 days 
                                               ^ 
90 i---------•450days 
80 
            5 10 1520 25 30 
                                                              days after Irrad.
        Fig. 19. Changes of hemoglobin contents in mice irradiated lethally and tre-
            ated with preserved IBM at -80°C. 
            The number of nucleated cells injected was 5 million. 
            Preservation was carried out in 15 % glycerol-Tyrode's solution for 120, 
           150, 180, 270, 360 and 450 days. 
   4) Histological findings. The examined tissues were femoral bone marrow, 
sternal bone marrow, thymus, mesenteric lymph node, brachial lymph node, and 
spleen. 
   Bone marrow. In both controls and mice treated with preserved IBM, only 
mature granulocytes and megakaryocytes remained in the bone marrow cavity 24 
hours after irradiation. In untreated mice the aplastic bone marrow persisted until 
the death of the animals. However, the bone marrow of mice which were killed 
10 days after irradiation showed a marked increase of reticular cells and scattered 
foci of hematopoiesis. 
   In mice treated with fresh bone marrow cells, early regeneration was initiated 
on the 4th day after irradiation. Scattered groups of regenerating young cells 
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        Table 4. The times of appearance of early regeneration and complete 
            recovery in the hematopoietic tissues in gamma-irradiated mice treated 
           with preserved IBM. 
 Preservation  Bone  MarrowSpleenThymus Lymph Node   periodred pulp white pulp 
            eg. cp. eg. cp. eg. cp. eg. cp. eg. cp. 
   Control 10  — 10 — — -- 10 — — — 
   Fresh 4 14 5 21 14 21 5 10 14 21 
  30 days 4 21 5 21 12 35 5 10 10 30 
  60 days 4 18 4 18 11 28 4 8 11 28 
  90 days 1 21 8 21 15 32 6 12 12 28 
  120 days 4 14 4 21 10 21 6 21 10 25 
  150 days 4 18 7 18 18 35 7 18 18 35 
  180 days 4 20 7 23 23 35 7 18 23 35 
 270 days 4 21 7 21 21 40 6 15 20 40 
 360 days 5 20 7 20 20 30 5 20 20 35 
 450 days 7 21 6 14 18 28 5 8 18 28 
      The number of nucleated cells injected was 5 million. They were preserved for 30 
  to 450 days at —80°C in 15% glycerol-Tyrode's solution. 
      Control means the group of gamma-irradiated mice treated with only Tyrode's 
   solution. 
      Fresh means the group of mice treated with fresh IBM. 
      eg. means early regeneration in the tissues in mice lethally irradiated and treated 
  with fresh and preserved IBM. 
      cp. means complete recovery in the tissues in the treated mice. 
      The numbers in Table show the days after irradiation. 
appeared. Collection of swollen reticular cells and undifferentiated immature cells 
(most of those are erythroblasts) existed in early regeneration. On the 5 to 6th 
day after irradiation the wasted bone marrow space was studded with foci or 
masses of immature blood forming cells. On the 8 th day the bone marrow showed 
cellularity of half of that in the normal bone marrow. On the 10 th day the cell-
ularity increased to 2/3 of the normal bone marrow cellularity. On the 14 th day 
the initially wasted bone marrow recovered to a normal cellularity. In the mice 
treated with 30 days preserved IBM, early regeneration was initiated on the 4 th 
day and the complete recovery of bone marrow occurred on the 21 st day after 
irradiation. 
   In the mice treated with 60 days preserved IBM, the early regeneration was 
initiated on the 4th day and the normal, much better to say hyperplastic, recovery 
occurred on the 18 th day after irradiation. In the mice treated with 90 days 
preserved IBM, early regeneration was initiated on the 4 th day and the bone 
marrow recovered to almost half a normal cellularity on the 14th day and complete 
recovery occurred on the 21 st day after irradiation. 
   In the mice treated with 120 days preserved IBM, early regeneration was 
initiated on the 4 th day and complete recovery of the wasted bone marrow occ-
urred on the 14 th day after irradiation. 
   In the mice treated with 150 clays preserved IBM, early regeneration was init-
iated on the 4th day and complete recovery occurred on the 18 th day after irrad-
iation. 
   In the mice treated with 180 days preserved IBM, early regeneration was init-
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iated on the 4th day and complete recovery occurred on the 20th day after irrad-
iation. 
   In the mice treated with 270 days preserved IBM, early regeneration was init-
iated on the 4th day and complete recovery occurred on the 21  st day after irrad-
iation. 
   In the mice treated with 360 days preserved IBM, early regeneration was init-
iated on the 5th day and complete recovery occurred on the 20th day after irrad-
iation. 
   In the mice treated with 450 days preserved IBM, early regeneration was init-
iated on the 7th day and complete recovery occurred on the 21 st day after irrad-
iation. 
   Consequently, the early regenerations of the lethally irradiated mice in each 
group were initiated on the 4 th to 7th after the transplantions of the isologous 
bone marrow cells which had been preserved at -80°C for 10 to 450 days. Except 
the treatments by 360 days and 450 days preserved IBM, all early regenerations 
occurred on the 4 th day after the treatments. 
   The complete recovery in the bone marrow in each group occurred between 
the 14 th to 21 st day after treatments. It is interesting to note that the longer-
term preserved bone marrow did not always delay the early regenerations and 
postpone complete recoveries. 
   Thymus 
   In 24 hours after irradiation, although almost complete disappearance of thy-
mocytes from the cortex occurred, a small number of thymocytes remained in the 
medulla in all animals. However, in 4 days after irradiation, the thymus was 
completely wasted. 
   In the mice treated with the fresh bone marrow, early regeneration was 
initiated in the medulla on the 5 th day and the thymus recovered to normal 
cellularity on the 10 th day after irradiation. 
   In the mice treated with 30 days preserved IBM, early regeneration was 
initiated on the 5th day and complete recovery occurred on the 10 th day after 
irradiation. 
   In the mice treated with 90 days preserved IBM, early regeneration occurred 
on the 6th day and complete recovery occurred on the 12 th day after irradiation. 
   In the mice treated with 360 days preserved IBM, early regeneration occurred 
on the 5th day and complete recovery occurred on the 15 th day after irradiation. 
   In the mice treated with 450 days preserved IBM, early regeneration and 
complete recovery occurred on the 5 th day and on the 8 th day after irradiation, 
respectively. 
   Spleen 
   Red pulp. Hematopoiesis is noticed in the splenic red pulp throughout mouse 
lifespan. During the 1st month after irradiation and bone marrow treatment, the 
spleen appears to be a blood-forming organ of prime importance. In the mice 
treated with the fresh bone marrow, the early regeneration was discernible on the 
5 th day and the complete recovery occurred on the 21st day after irradiation. 
   In the mice treated with 60 days preserved IBM, early regeneration occurred 
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on the 4th day and complete recovery occurred on the 18th day. 
   In the mice treated with 270 days preserved IBM, early regeneration occurred 
on the 7th day and complete regeneration occurred on the 21st day after irradiation. 
   In the mice treated with 450 days preserved IBM, early regeneration occurred 
on the 6th day and complete recovery occurred on the 14th day after irradiation. 
   The first signs of regeneration were discernible on the 4 to 8 th day and 
complete recovery was disdernible on the 14th to 21st clay after irradiation. 
   White pulp. The number of mature lymphocytes in the lymphatic tissues of 
spleen (white pulp) was greatly reduced 24 hours after irradiation. Reticular cells 
and pylcnotic lymphocytes remained. 
   In the mice treated with fresh IBM, early regeneration in the white pulp was 
discernible on the 14th day and complete recovery occurred on the 21 st day after 
irradiation. 
   In the mice treated with 180 days preserved IBM, early regeneration was 
discernible on the 23th day and complete recovery occurred on the 25th day after 
irradiation. 
   In the mice treated with 450 days preserved IBM, early regeneration was 
discernible on the 18th day and complete recovery occurred on the 28th day 
after irradiation. 
   The first sign of early regeneration which was noticed as the appearance of 
small groups of lymphoblasts was discernible on the 10 th to 23 th day and the 
complete recovery occurred on the 21st to 40th day after irradiation. 
   Lymph node 
   In the mice treated with fresh IBM, early regeneration occurred on the 10th 
day and complete recovery occurred on the 21st day after irradiation. 
   In the mice treated with 360 days preserved IBM, early regeneration occurred on 
the 20th day and the complete recovery occurred on the 35th day after irradiation. 
   In the mice treated with 450 days preserved IBM, early regeneration occurred 
on the 18th day and complete recovery occurred on the 28th day after irradiation. 
   The first signs of early regeneration in the lymphatic tissues were discernible 
on the 10th to 23th day and complete recoveries occurred on the 21st to 40th clay 
after irradiation. 
   The postirradiation days of early regenerations and complete recoveries in the 
hematopoietic tissues in the mice treated with fresh IBM and preserved IBM were 
shown in Table 4. 
                           DISCUSSION 
   Since the pioneer work of Lorenz many workers reported the successful expe-
riments in which the intravenous injection of isologous bone marrow protect well 
the total body lethally irradiated mice from hematopoietic death. Several wor-
kers" have shown by various methods that recovery is significant, if not entirely, 
due to recolonization of the normal cells injected in the host's radiation-damaged 
hematopoietic tissues. Evidence of Ford3506), Genogozian42, and Zaalbergl" indicated 
that the injected cells repopulate not only the bone marrow, but also the spleen, 
the thymus, and the lymphnodes. 
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   Early investigators of tissue transplantation were restricted in the avalability 
of human tissues for clinical use. It would be very convenient for the clinical or 
experimental investigators to keep preserved human or animal tissues ready to be 
used. The advances of modern cryptobiology have resolved the difficulties of 
adequate freezing techniques, knowledge of effective protective agents, and statis-
factory storage facilities. 
   The present experiments were carried out to protect the lethally irradiated 
mice with two combinations of bone marrow treatment and preservation. Under 
the condition of the experiments, a single total-body gamma-irradiation with 900r 
under high dose rate caused the death of all mice within 21 days after irradiation. 
The animals died of the bone marrow syndrome which was characterized by  sept-
icemia and hemorrhage. 
   1. The IBM which was preserved for 4 days at 0-4°C could not protect the 
lethally irradiated mice as well as the fresh bone marrow treatment. The IBM 
which was preserved for 14 days at 0-4°C could not protect the lethally irradiated 
mice. Urso") et al. reported that isologous bone marrow cells suspended in phy-
siological saline solution stored for 1 or 2 days at 4°C gave the 30 day-survival 
similar to that obtained by fresh bone marrow. As compared with the fresh IBM 
transplantation, the viability of bone marrow cells which were preserved at 0-4°C 
could be restrained within 3 days. 
   The least number of isologous bone marrow cells with which a half of the 
lethally irradiated mice could survive was 5 106 or less. However, Uchino and 
Yamagishi4" reported that one hundred thousand IBM cells gave approximately 
45% 30 day survival. According to Urso and Congdon4", the cell number of IBM 
was 0.6 x 106 or less. 
   To preserve the living cells or tissues for a long term, the first essential method 
is a reduction in the rate at which physical and chemical phenomena take place. 
This method was obtained by low temperatures, -80°C (ethanol and dry ice) or 
-196°C (liquid nitrogen). The dominant phemonena with lowering of temperature, 
is phase change, for an example, the freezing of water consists in the change of 
phase from liquid to crystalline solid. The formation of ice from water is one of 
the most important physical changes which take place when tissue is carried to 
low temperature. According to Meryman2900, and Mazur4", it seems that death is 
associated with direct effects of ice crystal formation and not the indirect effects 
of high solute concentration. The intracellular ice formation seems to be the lethal 
factor. The cells can survive total extracellular ice formation. 
   The IBM cells which were preserved for 2 hours at -80°C without protectives 
could not protect the lethally irradiated mice. However, Ferrebee'° reported that 
the bone marrow cells which were preserved for a few minutes at -80°C without 
protectives could protect the lethally irradiated mice. Meryman") reported that 
the living cells could be only protected from freezing injury, if the exposure to it 
had been brief, that is, a matter of minutes or seconds. 
   In 1949, Polge'2) and associates reported the first successful freezing of bovine 
semen with glycerol as protective medium. And then climethyl-sulphoxide'', and 
polyvinylpyrrolidons26) were found to be protectives from -freezing injury. The best 
protective compounds were found among either polyalcohols or monosaccharides. In 
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the bone marrow transplantation, no attempts were made to remove these com-
pounds after thawing for use. To preserve the bone marrow cells, the best method 
consists in suspending the cells in  15% glycerol-solution16,16,26_23,29) or in 10-15%13,26) 
DMSO solution. The best method of freezing and thawing was slow freezing and 
fast thawing. To know the best method of freezing and thawing, many combinations 
of freezing and thawing were carried out. Slow freezing is the best method to 
protect the intracellular ice formation2°,21,23,29,30' of cells. Slow freezing was obtained 
by many methods. Barnes et") al. reported the apparatus of slow freezing. The 
first step of slow freezing with which the bone marrow cells must be cooled at a 
rate 1-2°C/min. is achieved by many methods. The ampules were immersed in an 
ice-alcohol mixture") and placed in a freezer maintained at -25°C until their contents 
were solidly frozen. Placing the ampules in a freezer at -20°C for 25 minutes1e or 
1/3 V/V salt and 2/3 V/V ice pieces could cool the contents of the ampules at the 
rate of 1-2°C/min. The second step of slow freezing which means cooling the 
contents from -25°C to -80°C at a rate not exceeding 10°C/min. was achieved by 
the use of solid CO2 as coolant. 
   The IBM cells suspended in 15 % glycerol-Tyrode's solution or in 10% DMSO-
TC199 were used. The best 30 day-survival rates were obtained by the method of 
slow freezing and fast thawing in both suspensions. 
   2. Long-term preservation of isologous bone marrow cells. IBM cells suspended 
in 15% glycerol-Tyrode's solution were preserved for 10 to 450 days at -80°C by 
the method of slow freezing and fast thawing. 
   As for 30 days survival rates, the bone marrow cells which were preserved as 
long as 360 days could protect the lethally irradiated mice as well as the fresh 
IBM treatment. However, the survival rate of the mice treated with 450 days 
preserved IBM was 40% at 30 days as compared with 58 to 84% survival rates of 
the other treatments. As for 90 days survival, the bone marrow cells preserved as 
long as 270 days could protect the lethally irradiated mice as well as the fresh 
IBM treatment. 
   Cell viability. To test cell viability, there are many methods",","), such as 
enzymatic activity tests, cellular activity in tissue culture, mitotic figures, dye 
exclusion, and DNA synthesis. In these experiments eosin-uptake test was used, 
because an intact membrane of viable cells will presumably exclude such dyes as 
eosin. Eosin was usually prepared as a 0.2% Tyrode's solution. Generally speaking, 
the longer IBM cells were preserved, the more were there eosin-stained cells. The 
protective effect of bone marrow treatment itself was an evidence of cell viability. 
   The changes of body weight in the mice treated with preserved IBM were 
almost equal to the change of body weight in the mice treated with fresh IBM. 
However, the changes of body weight in the mice treated with 360 days preserved 
IBM or 450 days preserved IBM recovered to the preirradiation level later than 
those in the fresh IBM treatment. 
   The changes of hematological findings in the mice treated with preserved 
IBM were equal or later by 7 days than those in the fresh IBM treatment. The 
appearance of early regenerations in the bone marrow, the thymus, and the red 
pulp of spleen in the mice treated with preserved IBM were equal or 2 days later, 
as compared with that of the mice treated with fresh IBM. Complete recoveries 
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in them were equal or 10 days later than those in the fresh IBM treatment. 
   The appearance of early regenerations in the lymphatic tissues in the mice 
treated with preserved IBM was equal or 11 days later as compared with that in 
the fresh IBM treatment. Complete recoveries in them were equal or 20 days 
later than those in the fresh IBM treatment. It was expected that the longer the 
bone marrow cells were preserved, the later appeared the early regenerations and 
complete recoveries, but it was not necessarily so. 
   As for 30 day-survival rate, the survival rate of mice treated with fresh IBM 
was 68%, and the survival rate of mice treated with 270 days preserved IBM was 
71%. The survival rate in the mice treated with 360 days preserved IBM was 64 %. 
Based on these results, the following conclusions were drawn: if it is assumed 
that the lethally irradiated mice could be protected from death with bone marrow 
consisting of erythropoietic component and leucopoietic component in a certain 
ratio, the effect of freezing injury to the two components was equal. 
Bender") reported that the bone marrow cell suspended in 15% glycerol-solution 
which had been preserved for one year at -70°C could protect the lethally irrad-
iated mice. However, this was the survival at 30 days. 
   As for 30 days survival rate, the bone marrow cells preserved for one year in 
15% glycerol-Tyrode's solution, still retained the protective effect when the number 
of nucleated bone marrow cells injected was 5 million. 
   As for 90 days survival rate, the bone marrow cells preserved for 270 days in 
15% glycerol-Tyrode's solution was still effective when the number of cells injected 
was 5 million. 
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                     Explantation of Plates
Figs. 1-8: Bone marrows 
   Fig. 1. Bone marrow; 3 days after 900r gamma-irradiation. 
      The bone marrow is completely wasted. H-E stain x 100 
  Fig. 2. Bone marrow; 4 days after 900r gamma-irradiation and 60 days preserved IBM 
      treatment. A group of immature bone marrow cells are seen to have appeared from 
      the wasted bone marrow. H-E stain x 400 
  Fig. 3. Bone marrow; 4 days after 900r gamma-irradiation and 180 days preserved IBM 
      treatment. A group of immature bone marrow cells are seen. This is early regeneration. 
( 88 )
                Preserved Hematopoietic Tissues for Treatment of Mice (I) 
      H-E stain x 400 
   Fig. 4. Bone marrow; 4 days after 900r gamma-irradiation and 450 days preserved IBM 
       treatment. A group of immature bone marrow cells are seen. H-E stain x400 
   Fig. 5. Bone marrow; 7 days after 900r gamma-irradiation and 270 days preserved IBM 
       treatment. Marked regeneration is seen in the bone marrow. H-E stain x 400 
   Fig. 6. Bone marrow; 8 days  after 900r gamma-irradiation and fresh IBM treatment. The 
      cellularity is almost 2/3 of normal bone marrow. H-E stain x 400 
   Fig. 7. Bone marrow; 14 days after 900r gamma-irradiation and 60 days preserved IBM 
       treatment. The cellularity is half a normal bone marrow. H-E stain x 100 
   Fig. 8. Bone marrow; 28 days after 900r gamma-irradiation and 450 days preserved IBM 
       treatment. The cellularity is normal except for scattered areas of fatty change. H-E 
      stain x 100 
Figs. 9-17: Spleens 
   Fig. 9. Spleen; 4 days after 900r gamma-irradiation and fresh IBM treatment. The red 
      pulp is completely wasted. H-E stain x 400 
   Fig. 10. Spleen; 8 days after 900r gamma-irradiation and fresh IBM treatment. Immature 
      erythrocytic cells and myelocytic cells are seen in the red pulp. H-E stain x 400 
   Fig. U. Spleen; 14 days after 900r gamma-irradiation and 360 days preserved IBM treat-
      ment. Marked regeneration in the red pulp is seen and the white pulp is wasted. H-E 
      stain x 100 
   Fig. 12. Spleen; 10 days after 900r gamma-irradiation and GO days preserved IBM treat-
       ment. Marked regeneration of myelocytic and erythrocytic cells are seen in the red 
      pulp. H-E stain x 400 
   Fig. 13. Spleen; 7 days after 900r gamma-irradiation and 360 days preserved IBM treat-
      ment. The white pulp is completely wasted. H-E stain x 400 
   Fig. 14. Spleen; 16 days after 900r gamma-irradiation and fresh IBM treatment. Reticular 
      cells and little lymphocytes are seen in the white pulp. H-E stain x 400 
   Fig. 15. Spleen; 21 days after 900r gamma-irradiation and fresh IBM treatment. H-E stain 
x 400 
   Fig. 16. Spleen; 30 days after 900r gamma-irradiation and fresh IBM treatment. A marked 
      increase in number of lymphocytes in the white pulp. H-E stain x 400 
   Fig. 17. Spleen; 28 days after 900r gamma-irradiation and 450 days preserved IBM treat-
      ment. A marked increase in number of lymphocytes in the white pulp. H-E stain x 100 
Figs. 18-20: Thymus 
   Fig. 18. Thymus; 4 days after 900r gamma-irradiation and 450 days preserved IBM treat-
      ment. The thymus is completely wasted. H-E stain x 400 
   Fig. 19. Thymus ; 14 days after 900r gamma-irradiation and 360 days preserved IBM 
      treatment. Marked regeneration in the thymic medulla. H-E stain x 100 
   Fig. 20. Thymus ; 14 days after 900r gamma-irradiation and 450 days preserved IBM 
      treatment. The cellularity is normal. H-E stain x 100 
Figs. 21-24: Lymphnodes 
  Fig. 21. Mesenteric lymphnode ; 16 days after 900r gamma-irradiation and fresh IBM 
      treatment. The lymphnode is completely wasted. H-E stain x 400 
  Fig. 22. Mesenteric lymphnode; 14 days after 900r gamma-irradiation and 360 days pre-
      served IBM treatment. The lymphnode is completely wasted. H-E stain x 400 
  Fig. 23. Brachial lymphnode; 28 days after 900r gamma--irradiation and 450 days preserved 
      IBM treatment. H-E stain x 400 
  Fig. 24. Mesenteric lymphnode; 30 days after 900 r gamma-irradiation and fresh IBM 
      treatment. The cellularity is almost normal. H-E stain x400 
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